Barclays Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 18 04:32 ET · Ratings

Barclays Remains a Hold on Revance Therapeutics (RVNC)

TipRanksNov 18 04:07 ET · Ratings

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Moomoo NewsNov 13 03:31 ET · Ratings

Cautious Hold Rating on Revance Therapeutics Amid Ongoing Merger Uncertainties With Crown Laboratories

TipRanksNov 13 02:45 ET · Ratings

Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday

BenzingaNov 12 14:27 ET

Revance Therapeutics Jumps After Crown Laboratories Tender Offer Extended Again

Seeking AlphaNov 12 10:26 ET